Intro Pullout Text Widget

Drug and Therapeutics Bulletin

(DTB) covers practical, independent and evidence-based information on drugs, medication and prescribing.

Drug and Therapeutics Bulletin (DTB) publishes independent evaluations and practical advice on individual treatments and the overall management of disease. DTB summarises the best available evidence to enable doctors, pharmacists and other healthcare professionals to make informed and unbiased choices to help patients get the best care. DTB is wholly independent of the pharmaceutical industry, government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.

DTB publishes regular podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple, Google, Stitcher and Spotify.

Current Issue

Latest content

Highlighted Articles

Use of short-acting beta agonists in the treatment of asthma across five European countries

Concerns over haloperidol for treating delirium in older people

Dapagliflozin no longer licensed for type 1 diabetes

More evidence for low-dose aspirin in preventing pre-eclampsia

Subscribe to DTB

Our vision is to improve the health of patients through the safe and effective use of medicines. We do this though our mission to publish independent, practical, patient-orientated, evidence-based content on medicines for healthcare professionals.

We commission subject experts to review and reflect on the latest drugs and therapeutics issues facing healthcare professionals. All content is subject to a rigorous and transparent editorial process and is edited to present information in a coherent and concise format. Our content is independent of advertising and sponsorship.

Subscribe to DTB

About DTB